. Author manuscript; available in PMC: 2011 Mar 30.

Published in final edited form as: J Alzheimers Dis. 2011 Jan 1;24(1):187–196. doi: 10.3233/JAD-2010-101698

Table 2.

Statistical analysis of Alzheimer's disease-related pathology in all cases^* of Mumbai and New York samples

	Mumbai sample Mean (SEM)	New York sample Mean (SEM)	F	p
Brain weight	1034.34 g (14.92)	1209.03 g (14.42)	6.41	0.013
DP in Neocortex (grade)	1.79 (0.22)	0.78 (0.11)	5.67	0.019
NFT in Hippocampus (grade)	1.24 (0.18)	1.16 (0.18)	0.09	0.76, ns
NFT in Hippocampus (count/mm²)	4.41 (0.87)	3.78 (0.78)	0.01	0.95, ns
NFT in EC (grade)	1.39 (0.20)	1.32 (0.16)	1.33	0.25, ns
NFT in EC (count/mm²)	4.06 (0.71)	3.81 (0.63)	0.80	0.37, ns
SP in Neocortex (count/mm²)	1.15 (0.31)	0.59 (0.18)	0.79	0.37, ns
Braak stage for NFT	1.01 (0.14)	1.11 (0.12)	1.93	0.16, ns
SP, Age adjusted CERAD score	0.80 (0.17)	0.39 (0.11)	0.42	0.51, ns

n = 91; controlled for ages and genders.

Abbreviations: DP = diffuse plaques; NFT = neurofibrillary tangles; EC = entorhinal cortex; SP = senile plaques; CERAD = consortium to establish a registry for Alzheimer's disease.